Clinical trial · Interventional
Placing Trust in Endoscopic Ultrasonography: Impact on Planning Conformal Radiotherapy of Cancer of the Esophagus and Rectum
NCT02526134CI-TRIAL-00026266FIDUCORcompletedPhase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to estimate the rate of patients in whom a significant change in the area to be irradiated will be observed between the assessment before and after laying the evaluation of Trustees.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Oesophageal Cancer | — | UNRESOLVED | — |
| Rectal Cancer | Malignant Rectal Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| radio opaque markers (Echo Tip Ultra Fiducial Needle - ETUF) | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Laying of medical devices
- description
- radio opaque markers
- interventionNames
- Device: radio opaque markers (Echo Tip Ultra Fiducial Needle - ETUF)
Primary outcomes (1)
- measure
- Patients rate in which a significant variation in the area to be irradiated will be observed between before evaluation and evaluation after laying the trustees.
- timeFrame
- From inclusion to 12 months follow up
- description
- Observing whether there is a significant variation of the area to be irradiated
Secondary outcomes (1)
- measure
- Number of trustees (2 up 6 maximum) and set up their positions estimated success rate of implementation and the evaluation of the safety and toxicity (complications) associated with the establishment trustees (composite measure)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Male or female over the age of 18 * Rectal cancer diagnosis or esophagus * Radiotherapy indication * Signed consent to participate * Patient affiliated to a social security system or benefiting from such a system Exclusion Criteria: * Pregnant women, of child-bearing potential, or lactating women * Patient deprived of liberty or under supervision of a guardian * Impossibility to undergo medical examinations of the study for geographical, social or psychological reasons * Contra-indication for procedure study (infeasible EUS) * Contra-indication for general anesthesia * Patient (e) with disorders of hemostasis * Patient (e) with portal hypertension
References
Publications (0)
Data not yet available
No reference posted for this study.